127 related articles for article (PubMed ID: 23419645)
1. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles.
Wadajkar AS; Menon JU; Tsai YS; Gore C; Dobin T; Gandee L; Kangasniemi K; Takahashi M; Manandhar B; Ahn JM; Hsieh JT; Nguyen KT
Biomaterials; 2013 May; 34(14):3618-25. PubMed ID: 23419645
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
3. Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications.
Sundaresan V; Menon JU; Rahimi M; Nguyen KT; Wadajkar AS
Int J Pharm; 2014 May; 466(1-2):1-7. PubMed ID: 24607216
[TBL] [Abstract][Full Text] [Related]
4. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
Kalambur VS; Longmire EK; Bischof JC
Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940
[TBL] [Abstract][Full Text] [Related]
5. Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers.
Pandey N; Menon JU; Takahashi M; Hsieh JT; Yang J; Nguyen KT; Wadajkar AS
Nanotheranostics; 2020; 4(1):1-13. PubMed ID: 31911890
[TBL] [Abstract][Full Text] [Related]
6. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
[TBL] [Abstract][Full Text] [Related]
7. A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA.
Zhang T; Xue X; He D; Hsieh JT
Cancer Lett; 2015 Sep; 365(2):156-65. PubMed ID: 26054847
[TBL] [Abstract][Full Text] [Related]
8. Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles.
Jiang J; Chen Y; Zhu Y; Yao X; Qi J
Cancer Biother Radiopharm; 2011 Aug; 26(4):461-7. PubMed ID: 21812654
[TBL] [Abstract][Full Text] [Related]
9. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
[TBL] [Abstract][Full Text] [Related]
10. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
11. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
12. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.
Tan YF; Chandrasekharan P; Maity D; Yong CX; Chuang KH; Zhao Y; Wang S; Ding J; Feng SS
Biomaterials; 2011 Apr; 32(11):2969-78. PubMed ID: 21257200
[TBL] [Abstract][Full Text] [Related]
13. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.
Serda RE; Adolphi NL; Bisoffi M; Sillerud LO
Mol Imaging; 2007; 6(4):277-88. PubMed ID: 17711783
[TBL] [Abstract][Full Text] [Related]
14. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.
Lartigue L; Hugounenq P; Alloyeau D; Clarke SP; Lévy M; Bacri JC; Bazzi R; Brougham DF; Wilhelm C; Gazeau F
ACS Nano; 2012 Dec; 6(12):10935-49. PubMed ID: 23167525
[TBL] [Abstract][Full Text] [Related]
15. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
16. In vitro biocompatibility of magnetic thermo-responsive nanohydrogel particles of poly(N-isopropylacrylamide-co-acrylic acid) with Fe3O4 cores: effect of particle size and chemical composition.
Chou FY; Lai JY; Shih CM; Tsai MC; Lue SJ
Colloids Surf B Biointerfaces; 2013 Apr; 104():66-74. PubMed ID: 23298590
[TBL] [Abstract][Full Text] [Related]
17. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
18. Temperature-responsive magnetite/PEO-PPO-PEO block copolymer nanoparticles for controlled drug targeting delivery.
Chen S; Li Y; Guo C; Wang J; Ma J; Liang X; Yang LR; Liu HZ
Langmuir; 2007 Dec; 23(25):12669-76. PubMed ID: 17988160
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers.
Mi Y; Liu X; Zhao J; Ding J; Feng SS
Biomaterials; 2012 Oct; 33(30):7519-29. PubMed ID: 22809649
[TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition.
Dabbagh A; Hedayatnasab Z; Karimian H; Sarraf M; Yeong CH; Madaah Hosseini HR; Abu Kasim NH; Wong TW; Rahman NA
Int J Hyperthermia; 2019; 36(1):104-114. PubMed ID: 30428737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
